The introduction of nicotinamide to be a nicotine alternative in e-cigarette and smokeless items represents a big regulatory challenge to the FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to act as a sedative at superior dosages6. The claims created by Nicotine